Literature DB >> 12037029

The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry.

J A W M van der Laak1, L M T de Bie, H de Leeuw, P C M de Wilde, A G J M Hanselaar.   

Abstract

BACKGROUND: After the menopause decreased concentrations of oestrogen may result in insufficient maturation of the vaginal epithelium, which can lead to a range of vaginal discomforts. This state of vaginal atrophy may be treated with oestrogen replacement treatment. Replens, a non-hormonal alternative to oestrogen replacement treatment has been shown to be effective in relieving symptoms related to vaginal atrophy in previous studies. AIMS: To study the effect of Replens on the maturation of the vaginal epithelium and morphology of the vaginal cells and to compare the results of a recently developed cytomorphometric method with manual assessment of the degree of maturation in vaginal smears.
METHODS: Vaginal smears from 38 postmenopausal women suffering from symptoms related to vaginal atrophy were analysed manually and by cytomorphometry. The maturation value (MV) and the percentages of (para)basal, intermediate, and superficial cells (maturation index; MI) were measured by both methods before and after treatment with Replens. Cytomorphometry also measured mean cellular area, mean nuclear area, and mean area ratio.
RESULTS: A correlation was shown between the two methods in the assessment of percentages of (para) basal and intermediate cells and MV. Cytomorphometric data showed a significant increase in mean cellular area, indicating a positive effect of Replens on the maturation of the vaginal epithelium. Changes in nuclear area and ratio between nuclear and cellular areas were not significant. Treatment with Replens did not influence MI or MV, as assessed by the two methods.
CONCLUSIONS: Replens did have an effect on vaginal morphology. The automated procedure may be useful for the assessment of maturation in vaginal smears and is more sensitive to small (subvisual) changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037029      PMCID: PMC1769660          DOI: 10.1136/jcp.55.6.446

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Development and validation of a computerized cytomorphometric method to assess the maturation of vaginal epithelial cells.

Authors:  J A van der Laak; C P Schijf; H M Kerstens; T H Heijnen-Wijnen; P C de Wilde; G J Hanselaar
Journal:  Cytometry       Date:  1999-03-01

2.  The maturation value.

Authors:  A Meisels
Journal:  Acta Cytol       Date:  1967 Jul-Aug       Impact factor: 2.319

3.  The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment.

Authors:  K Nilsson; B Risberg; G Heimer
Journal:  Maturitas       Date:  1995-01       Impact factor: 4.342

4.  Comparative study: Replens versus local estrogen in menopausal women.

Authors:  L E Nachtigall
Journal:  Fertil Steril       Date:  1994-01       Impact factor: 7.329

5.  Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function.

Authors:  G B Hubbard; K D Carey; H Levine; G A Bachmann
Journal:  Lab Anim Sci       Date:  1997-02

6.  Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.

Authors:  R Trevoux; W H van der Velden; D Popović
Journal:  Reproduccion       Date:  1982 Apr-Jun

7.  The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects.

Authors:  P M Kicovic; J Cortes-Prieto; S Milojević; A A Haspels; A Aljinovic
Journal:  Maturitas       Date:  1980-12       Impact factor: 4.342

8.  Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.

Authors:  M Bygdeman; M L Swahn
Journal:  Maturitas       Date:  1996-04       Impact factor: 4.342

  8 in total
  10 in total

Review 1.  How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer.

Authors:  Sharon L Bober; Jennifer B Reese; Lisa Barbera; Andrea Bradford; Kristen M Carpenter; Shari Goldfarb; Jeanne Carter
Journal:  Curr Opin Support Palliat Care       Date:  2016-03       Impact factor: 2.302

Review 2.  A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Authors:  Mariana S Sousa; Michelle Peate; Sherin Jarvis; Martha Hickey; Michael Friedlander
Journal:  Ther Adv Med Oncol       Date:  2017-01-31       Impact factor: 8.168

3.  Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.

Authors:  Sabrina Witherby; Julia Johnson; Laurence Demers; Sharon Mount; Benjamin Littenberg; Charles D Maclean; Marie Wood; Hyman Muss
Journal:  Oncologist       Date:  2011-03-08

4.  Genistein anticancer efficacy during induced oral squamous cell carcinoma: an experimental study.

Authors:  Ahmed M Hussein; Abdelraheim H Attaai; Asmaa M Zahran
Journal:  J Egypt Natl Canc Inst       Date:  2022-09-05

5.  Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Authors:  Nancy S Padian; Ariane van der Straten; Gita Ramjee; Tsungai Chipato; Guy de Bruyn; Kelly Blanchard; Stephen Shiboski; Elizabeth T Montgomery; Heidi Fancher; Helen Cheng; Michael Rosenblum; Mark van der Laan; Nicholas Jewell; James McIntyre
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

Review 6.  Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.

Authors:  Laura B Huffman; Ellen M Hartenbach; Jeanne Carter; Joanne K Rash; David M Kushner
Journal:  Gynecol Oncol       Date:  2015-11-07       Impact factor: 5.482

7.  The effect of vitamin D on vaginal atrophy in postmenopausal women.

Authors:  Parastou Rad; Mitra Tadayon; Mohammadreza Abbaspour; Seyed Mahmood Latifi; Iran Rashidi; Hamdollah Delaviz
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Mar-Apr

8.  Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study.

Authors:  Nicoletta De Rosa; Giada Lavitola; Pierluigi Giampaolino; Ilaria Morra; Carmine Nappi; Giuseppe Bifulco
Journal:  Biomed Res Int       Date:  2017-07-11       Impact factor: 3.411

Review 9.  Management of genitourinary syndrome of menopause in breast cancer survivors: An update.

Authors:  Daniel María Lubián López
Journal:  World J Clin Oncol       Date:  2022-02-24

10.  Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy.

Authors:  Sharon J Parish; Rossella E Nappi; Michael L Krychman; Susan Kellogg-Spadt; James A Simon; Jeffrey A Goldstein; Sheryl A Kingsberg
Journal:  Int J Womens Health       Date:  2013-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.